BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 36448770)

  • 1. Emerging theranostics to combat cancer: a perspective on metal-based nanomaterials.
    Agnihotri TG; Gomte SS; Jain A
    Drug Dev Ind Pharm; 2022 Nov; 48(11):585-601. PubMed ID: 36448770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanotheranostics: The Fabrication of Theranostics with Nanoparticles and their Application to Treat the Neurological Disorders.
    Singh A; Patel A; Chaudhary H; Yadav K; Minocha N
    Recent Pat Nanotechnol; 2023 Jul; ():. PubMed ID: 37464820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nano-Theranostics for the Sensing, Imaging and Therapy of Prostate Cancers.
    Calatayud DG; Neophytou S; Nicodemou E; Giuffrida SG; Ge H; Pascu SI
    Front Chem; 2022; 10():830133. PubMed ID: 35494646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Challenges to effective cancer nanotheranostics.
    Melancon MP; Stafford RJ; Li C
    J Control Release; 2012 Dec; 164(2):177-82. PubMed ID: 22906841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospects of microbial-engineering for the production of graphene and its derivatives: Application to design nanosystms for cancer theranostics.
    Singh R; Alshaghdali K; Saeed A; Kausar MA; Aldakheel FM; Anwar S; Mishra D; Srivastava M
    Semin Cancer Biol; 2022 Nov; 86(Pt 3):885-898. PubMed ID: 34020029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metallic Nanoclusters for Cancer Imaging and Therapy.
    Zhang Q; Yang M; Zhu Y; Mao C
    Curr Med Chem; 2018; 25(12):1379-1396. PubMed ID: 28393695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer Nanotheranostics: A Nanomedicinal Approach for Cancer Therapy and Diagnosis.
    Kundu P; Singh D; Singh A; Sahoo SK
    Anticancer Agents Med Chem; 2020; 20(11):1288-1299. PubMed ID: 31429694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent Trends and Developments in Multifunctional Nanoparticles for Cancer Theranostics.
    Rabaan AA; Bukhamsin R; AlSaihati H; Alshamrani SA; AlSihati J; Al-Afghani HM; Alsubki RA; Abuzaid AA; Al-Abdulhadi S; Aldawood Y; Alsaleh AA; Alhashem YN; Almatouq JA; Emran TB; Al-Ahmed SH; Nainu F; Mohapatra RK
    Molecules; 2022 Dec; 27(24):. PubMed ID: 36557793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advancements in Applications of Surface Modified Nanomaterials for Cancer Theranostics.
    Ahmad IZ; Kuddus M; Tabassum H; Ahmad A; Mabood A
    Curr Drug Metab; 2017; 18(11):983-999. PubMed ID: 28969548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Choice of Nanoparticles for Theranostics Engineering: Surface Coating to Nanovalves Approach.
    Prasad R; Selvaraj K
    Nanotheranostics; 2024; 8(1):12-32. PubMed ID: 38164501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amino acids and doxorubicin as building blocks for metal ion-driven self-assembly of biodegradable polyprodrugs for tumor theranostics.
    Wang D; Zhang N; Yang T; Zhang Y; Jing X; Zhou Y; Long J; Meng L
    Acta Biomater; 2022 Jul; 147():245-257. PubMed ID: 35487428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Smart Multifunctional Nanoparticles in Cancer Theranostics: Progress and Prospect.
    Karati D; Mukherjee S; Dutta A; Ash D; Ganguly SC; Acharya A; Basu B
    Pharm Nanotechnol; 2024 May; ():. PubMed ID: 38756071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanotheranostics for personalized medicine.
    Kim TH; Lee S; Chen X
    Expert Rev Mol Diagn; 2013 Apr; 13(3):257-69. PubMed ID: 23570404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protease-activated nanomaterials for targeted cancer theranostics.
    Chan YC; Hsiao M
    Nanomedicine (Lond); 2017 Sep; 12(18):2153-2159. PubMed ID: 28814163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nano Metal Based Herbal Theranostics for Cancer Management: Coalescing Nature's Boon with Nanotechnological Advancement.
    Pandey Y; Ambwani S
    Curr Pharm Biotechnol; 2022; 23(1):30-46. PubMed ID: 33480341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineered extracellular vesicles-like biomimetic nanoparticles as an emerging platform for targeted cancer therapy.
    Liu X; Xiao C; Xiao K
    J Nanobiotechnology; 2023 Aug; 21(1):287. PubMed ID: 37608298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of Theranostics in Oncology.
    Lymperopoulos G; Lymperopoulos P; Alikari V; Dafogianni C; Zyga S; Margari N
    Adv Exp Med Biol; 2017; 989():119-128. PubMed ID: 28971421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advancing cancer theranostics through biomimetics: A comprehensive review.
    Anitha K; Chenchula S; Surendran V; Shvetank B; Ravula P; Milan R; Chikatipalli R; R P
    Heliyon; 2024 Mar; 10(6):e27692. PubMed ID: 38496894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advancement in Biopolymer Assisted Cancer Theranostics.
    Bhattacharya T; Preetam S; Ghosh B; Chakrabarti T; Chakrabarti P; Samal SK; Thorat N
    ACS Appl Bio Mater; 2023 Oct; 6(10):3959-3983. PubMed ID: 37699558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photonic nanoparticles: emerging theranostics in cancer treatment.
    Shahcheraghi SH; Shahcheraghi SH; Lotfi M; Lotfi M; Khaleghinejad SH; Tambuwala ZM; Mishra V; Mishra Y; Serrano-Aroca Á; A Aljabali AA; El-Tanani M; Naikoo GA; Chava SR; Charbe NB; Bharti S; Jaganathan SK; Goyal R; Negi P; Tambuwala MM; Folorunso O
    Ther Deliv; 2023 Apr; 14(4):311-329. PubMed ID: 37403985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.